VIVS - ORGANOVO HOLDINGS, INC.
1.83
-0.050 -2.732%
Share volume: 28,994
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$1.88
-0.05
-0.03%
View ratios
| Fiscal Date | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
| Report Date | 08-05-2024 | 11-08-2024 | 02-19-2025 | 06-05-2025 | 08-12-2025 | |
| Assets | ||||||
| Total Assets | 9.470 M | 6.754 M | 3.844 M | 14.650 M | 11.978 M | |
| Current Assets | 7.283 M | 4.783 M | 2.100 M | 12.131 M | 9.679 M | |
| Inventories | 408.000 K | 640.000 K | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 6.187 M | 3.174 M | 1.161 M | 11.312 M | 9.055 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 601.000 K | 545.000 K | 479.000 K | 419.000 K | 359.000 K | |
| Other Assets | 1.586 M | 1.426 M | 1.265 M | 2.100 M | 1.940 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 9.470 M | 6.754 M | 3.844 M | 14.650 M | 11.978 M | |
| Total liabilities | 2.808 M | 3.074 M | 3.480 M | 4.158 M | 2.440 M | |
| Total current liabilities | 2.033 M | 2.414 M | 2.937 M | 3.737 M | 2.142 M | |
| Accounts Payable | 1.119 M | 419.000 K | 930.000 K | 1.644 M | 673.000 K | |
| Other liabilities | 775.000 K | 660.000 K | 543.000 K | 421.000 K | 298.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 775.000 K | 660.000 K | 543.000 K | 421.000 K | 298.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 6.662 M | 3.680 M | 364.000 K | 10.492 M | 9.538 M | |
| Common stock | 349.676 M | 349.242 M | 349.374 M | 352.650 M | 354.538 M | |
| Retained earnings | -343.013 M | -345.562 M | -349.009 M | -342.157 M | -345.000 M |